Listen in as our editors discuss several novel drugs approved in 2025, including two new eye drops, a new topical for chronic hand eczema, and an oral nonhormonal option for patients with menopausal hot flashes. They’ll review efficacy, safety, and considerations for use with these new treatment options.

• Aceclidine 1.44% Drops (Vizz) for Presbyopia
• Acoltremon 0.003% Drops (Tryptyr) for Dry Eye
• Delgocitinib (Anzupgo) 2% Cream for Chronic Hand Eczema
• Elinzanetant (Lynkuet) for Hot Flashes

Use code mt1026 at checkout for 10% off a new or upgraded subscription.

******

TRC Healthcare Editors: 

• Sara Klockars, PharmD, BCPS
• Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC 

******

This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in December 2025.

******

CE Information:

None of the speakers have anything to disclose. 

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

******

The clinical resources related to this podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: 

• Article: Have Treatment Options in Sight for Dry Eye Disease
• Chart: Treatments for Dry Eyes
• Chart: Managing Eczema
• Article: Elinzanetant: Emerging Therapy for Menopausal Hot Flashes
• Chart: Managing Vasomotor Menopause Symptoms
• FAQ: Managing Genitourinary Menopausal Symptoms
• Chart: Menopausal Hormone Therapies

Send us a text

Email us: [email protected].

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.